Return to List

Study Summary
No. 2006-0102:.......Brain......Jeffrey Weinberg......Neurosurgery
.
Study Summary Title
Study Summary
Number:
2006-0102
Study Title: Intraoperative Optical Imaging of Brain Function
.
Physician New Patient Referral
Name:Jeffrey WeinbergPatients Call:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Dept:NeurosurgeryReferring MD
Call:
800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Phone:713-792-2400
Contact us about clinical trials
.
General Information
Disease Group:BrainSupported By:N/A
Phase of Study:N/AReturn
Visit:
None
Treatment
Agents:
NoneHome Care:None
Treatment Loc:Only at MDACC
Estimated
Length of Stay
in Houston:
Patients will be hospitalized for 3 to 4 days for the craniotomy which is
standard and not affected by enrollment on the protocol.
Description/
Intervention:
The goal of this clinical research study is to test a new kind of scan called
speckle-contrast imaging that may help researchers more easily find areas of
the brain during surgery that control functions such as finger movement and
feeling.
.
Study Objectives / Outcomes
The goal of this proposal is to test the performance of a novel optical imaging system for real-time quantitative imaging of brain function through multiple hemodynamic measures during neurosurgery.

This pilot study encompasses two sub-aims:

Aim 1. Evaluate the ability of laser speckle contrast imaging to image cerebral blood flow (CBF) intraoperatively. We will image the changes in CBF in response to somatosensory stimulation. (5 patients).

Aim 2.Simultaneously image hemoglobin oxygenation, blood volume, blood flow, and cerebral metabolic rate of oxygen (CMRO2) changes during somatosensory stimulation using a combined laser speckle and multi-wavelength reflectance imaging system. (5 patients).
.
Study Status Information
Study Activation / Registration Date:02/11/2008
IRB Review and Approval Date:06/09/2006
Study Type:Other
Recruitment Status:Terminated
Projected Accrual:N/A
.
Enrollment Eligibility
If you do not meet the enrollment eligibility, there may be other treatment options for you. Please Contact the Referral Office for more information.

Inclusion Criteria:1) Location of planned resection near somatosensory cortex.

2) Planned intraoperative electrocortical mapping.

3) Able to render written informed consent.

Exclusion Criteria:1) Patients with a hemiparesis graded 3/5 (active movement against gravity) or worse that is attributable to the lesion undergoing resection. Unpublished data from MDACC Department of Neurosurgery suggests that cortical mapping is ineffective in these patients because an adequate cortical response is not detected

2) Patients with a vascular malformation within the proximity of the cortex area imaged.

.
Links
Registration Number: NCT00632437
Study Information on Clinical Trials Registry (clinicaltrials.gov)

Other Links:
.
Results


Return to Clinical Trials at M.D. Anderson Cancer Center